Bioavailability of Plant Protein Amino Acids
Bioavailability of Amino Acids and Metabolic Products Following Oral Ingestion of Plant-Based Proteins in Young, Healthy Men and Women Aged 18-35y
1 other identifier
interventional
10
1 country
1
Brief Summary
This study aims to inform of the mechanism of action of plant-based protein by measuring the bioavailability (i.e. rate of appearance and magnitude of concentration in the circulation following oral ingestion) of key amino acid and metabolic products that regulate skeletal muscle protein synthesis (MPS) in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2020
CompletedFirst Submitted
Initial submission to the registry
April 29, 2021
CompletedFirst Posted
Study publicly available on registry
May 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2023
CompletedNovember 30, 2023
November 1, 2023
1.4 years
April 29, 2021
November 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma amino acids
Plasma amino acids measured by HPLC
3 hours
Study Arms (6)
Pea-protein concentrate
EXPERIMENTALPea-protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Fava-bean protein concentrate
EXPERIMENTALFava-bean protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Chickpea protein concentrate
EXPERIMENTALChickpea protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Red lentil protein concentrate
EXPERIMENTALRed lentil protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Non-essential amino acid blend
EXPERIMENTALNon-essential amino acid blend dosed at 0.33 g/kg body mass in 500 ml of water.
Whey protein concentrate
EXPERIMENTALWhey protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Interventions
Fava-bean protein concentrate
Chickpea protein concentrate
Red lentil protein concentrate
Non-essential amino acid blend
Eligibility Criteria
You may qualify if:
- No known intolerance to any item contained in the protein products.
- No blood borne disease risk, current illness or medication that would adversely affect participation
- No known adverse reaction to venepuncture
You may not qualify if:
- n/a
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Limericklead
- Marigot Ltd.collaborator
- Enterprise Irelandcollaborator
Study Sites (1)
Education and Health Sciences
Limerick, V94 T9PX, Ireland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Phil Jakeman, PhD
University of Limerick
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2021
First Posted
May 4, 2021
Study Start
January 8, 2020
Primary Completion
May 31, 2021
Study Completion
September 29, 2023
Last Updated
November 30, 2023
Record last verified: 2023-11